Skip to main content
Clinical Trials/CTIS2024-510921-25-00
CTIS2024-510921-25-00
Recruiting
Phase 1

Antibiotic Impregnated Bone Graft to reduce infection in hip replacement - the ABOGRAFT trial

Region Oestergoetland0 sites850 target enrollmentMarch 8, 2024

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Prosthetic Joint Infection
Sponsor
Region Oestergoetland
Enrollment
850
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 8, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Region Oestergoetland

Eligibility Criteria

Inclusion Criteria

  • Age \= 18 years, Hip arthroplasty requiring bone graft, Willing to provide informed consent, For women of childbearing potential; a negative pregnancy test prior to reoperation

Exclusion Criteria

  • Ongoing prosthetic joint infection, Known allergies and contraindications for the use of vancomycin or tobramycin, Mental inability, reluctance, or language difficulties that according to investigator judgement, result in difficulty understanding the meaning of study participation, Expected difficulties to complete 2\-year follow\-up, Women of child bearing potential not using contraception, Pregnant women, Nursing women

Outcomes

Primary Outcomes

Not specified

Similar Trials